
James C. Housel
Examiner (ID: 6756)
| Most Active Art Unit | 1305 |
| Art Unit(s) | 1305, 1648, 1307, 1802, 1809, 1641, 1308 |
| Total Applications | 725 |
| Issued Applications | 585 |
| Pending Applications | 32 |
| Abandoned Applications | 108 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20771746
[patent_doc_number] => 12655407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome
[patent_app_type] => utility
[patent_app_number] => 19/347136
[patent_app_country] => US
[patent_app_date] => 2025-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 54
[patent_no_of_words] => 48342
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19347136
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/347136 | Engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome | Sep 30, 2025 | Issued |
Array
(
[id] => 20567120
[patent_doc_number] => 20260061038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-05
[patent_title] => COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES
[patent_app_type] => utility
[patent_app_number] => 19/315951
[patent_app_country] => US
[patent_app_date] => 2025-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19315951
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/315951 | COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES | Sep 1, 2025 | Pending |
Array
(
[id] => 20426826
[patent_doc_number] => 20250388914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => UV-RESISTANT BIOLOGICAL DEVICES AND EXTRACTS AND METHODS FOR PRODUCING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 19/312528
[patent_app_country] => US
[patent_app_date] => 2025-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19312528
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/312528 | UV-RESISTANT BIOLOGICAL DEVICES AND EXTRACTS AND METHODS FOR PRODUCING AND USING THE SAME | Aug 27, 2025 | Pending |
Array
(
[id] => 20459616
[patent_doc_number] => 20260009039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => ANTI-MICROBIAL AND UV-PROTECTIVE EXTRACTS AND METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/312553
[patent_app_country] => US
[patent_app_date] => 2025-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19312553
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/312553 | ANTI-MICROBIAL AND UV-PROTECTIVE EXTRACTS AND METHODS OF MAKING AND USING THEREOF | Aug 27, 2025 | Pending |
Array
(
[id] => 20676454
[patent_doc_number] => 20260115263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-30
[patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration
[patent_app_type] => utility
[patent_app_number] => 19/307581
[patent_app_country] => US
[patent_app_date] => 2025-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19307581
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/307581 | Hyaluronidase Enzyme Formulations for High Volume Administration | Aug 21, 2025 | Pending |
Array
(
[id] => 20426599
[patent_doc_number] => 20250388686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => COMPOSITIONS OF IL-1R1 ANTIBODIES AND METHODS OF PRODUCING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 19/273461
[patent_app_country] => US
[patent_app_date] => 2025-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19273461
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/273461 | Compositions of IL-1R1 antibodies and methods of producing and using the same | Jul 17, 2025 | Issued |
Array
(
[id] => 20729106
[patent_doc_number] => 12636350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Hyaluronidase enzyme formulations for high volume administration
[patent_app_type] => utility
[patent_app_number] => 19/242226
[patent_app_country] => US
[patent_app_date] => 2025-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 199
[patent_figures_cnt] => 226
[patent_no_of_words] => 85054
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19242226
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/242226 | Hyaluronidase enzyme formulations for high volume administration | Jun 17, 2025 | Issued |
Array
(
[id] => 20231372
[patent_doc_number] => 20250288691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 19/224549
[patent_app_country] => US
[patent_app_date] => 2025-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224549
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/224549 | Compositions and methods for epigenetic regulation of HBV gene expression | May 29, 2025 | Issued |
Array
(
[id] => 19989643
[patent_doc_number] => 20250127865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration
[patent_app_type] => utility
[patent_app_number] => 18/940001
[patent_app_country] => US
[patent_app_date] => 2024-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/940001 | Hyaluronidase enzyme formulations for high volume administration | Nov 6, 2024 | Issued |
Array
(
[id] => 19989644
[patent_doc_number] => 20250127866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-24
[patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration
[patent_app_type] => utility
[patent_app_number] => 18/940031
[patent_app_country] => US
[patent_app_date] => 2024-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/940031 | Hyaluronidase enzyme formulations for high volume administration | Nov 6, 2024 | Issued |
Array
(
[id] => 19832636
[patent_doc_number] => 20250084422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => Recombinant of Hydrogenophilus Bacterium with Enhanced Ability to Produce Valine
[patent_app_type] => utility
[patent_app_number] => 18/937712
[patent_app_country] => US
[patent_app_date] => 2024-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18937712
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/937712 | None | Nov 4, 2024 | Issued |
Array
(
[id] => 20144202
[patent_doc_number] => 12378532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Food composition containing novel aldehyde dehydrogenase for improving memory and cognitive function
[patent_app_type] => utility
[patent_app_number] => 18/935987
[patent_app_country] => US
[patent_app_date] => 2024-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 28
[patent_no_of_words] => 7423
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18935987
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/935987 | Food composition containing novel aldehyde dehydrogenase for improving memory and cognitive function | Nov 3, 2024 | Issued |
Array
(
[id] => 19875839
[patent_doc_number] => 20250108096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => ALCOHOL CLEANSING METHODS
[patent_app_type] => utility
[patent_app_number] => 18/900033
[patent_app_country] => US
[patent_app_date] => 2024-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/900033 | ALCOHOL CLEANSING METHODS | Sep 26, 2024 | Pending |
Array
(
[id] => 19709277
[patent_doc_number] => 20250019419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => PRODUCTION METHOD FOR PRODUCT AND PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/898929
[patent_app_country] => US
[patent_app_date] => 2024-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18898929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/898929 | PRODUCTION METHOD FOR PRODUCT AND PRODUCT | Sep 26, 2024 | Pending |
Array
(
[id] => 19693188
[patent_doc_number] => 20250011733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => BIOCATALYSTS FOR EZETIMIBE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/886292
[patent_app_country] => US
[patent_app_date] => 2024-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/886292 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | Sep 15, 2024 | Pending |
Array
(
[id] => 19890582
[patent_doc_number] => 20250115894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 18/885576
[patent_app_country] => US
[patent_app_date] => 2024-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 789
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885576
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/885576 | Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof | Sep 13, 2024 | Pending |
Array
(
[id] => 19940495
[patent_doc_number] => 12312617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Cell wall hydrolases targeting c. acnes
[patent_app_type] => utility
[patent_app_number] => 18/882341
[patent_app_country] => US
[patent_app_date] => 2024-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 62
[patent_no_of_words] => 41227
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/882341 | Cell wall hydrolases targeting c. acnes | Sep 10, 2024 | Issued |
Array
(
[id] => 20165330
[patent_doc_number] => 20250257376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => GENERATION OF ACYL ALCOHOLS
[patent_app_type] => utility
[patent_app_number] => 18/828699
[patent_app_country] => US
[patent_app_date] => 2024-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18828699
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/828699 | GENERATION OF ACYL ALCOHOLS | Sep 8, 2024 | Pending |
Array
(
[id] => 19940497
[patent_doc_number] => 12312619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Deaminases and variants thereof for use in base editing
[patent_app_type] => utility
[patent_app_number] => 18/814865
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 19
[patent_no_of_words] => 14813
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18814865
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/814865 | Deaminases and variants thereof for use in base editing | Aug 25, 2024 | Issued |
| 18/835660 | DEAMINASES AND VARIANTS THEREOF FOR USE IN BASE EDITING | Aug 1, 2024 | Pending |